Although arsenic is a well-established human carcinogen, the mechanisms by
which it induces cancer remain poorly understood. We previously showed arse
nite to be a potent mutagen in human-hamster hybrid (A(L)) cells, and that
it induces predominantly multilocus deletions. We show here by confocal sca
nning microscopy with the fluorescent probe 5'.6'-chloromethyl-2'.7'-dichlo
rodihydrofluorescein diacetate that arsenite induces, within 5 min after tr
eatment, a dose-dependent increase of up to 3-fold in intracellular oxyradi
cal production. Concurrent treatment of cells with arsenite and the radical
scavenger DMSO reduced the fluorescent intensity to control levels. ESR sp
ectroscopy with 4-hydroxy-2,2.6,6-tetramethyl-1-hydroxypiperidine (TEMPOL-H
) as a probe in conjunction with superoxide dismutase and catalase to quenc
h superoxide anions and hydrogen peroxide, respectively, indicates that ars
enite increases the levels of superoxide-driven hydroxyl radicals in these
cells. Furthermore, reducing the intracellular levels of nonprotein sulfhyd
ryls (mainly glutathione) in A(L) cells with buthionine S-R-sulfoximine inc
reases the mutagenic potential of arsenite by more than 5-fold. The data ar
e consistent with our previous results with the radical scavenger DMSO, whi
ch reduced the mutagenicity of arsenic in these cells, and provide convinci
ng evidence that reactive oxygen species, particularly hydroxyl radicals, p
lay an important causal role in the genotoxicity of arsenical compounds in
mammalian cells.